← FDA Drug Approvals (Drugs@FDA)
CANAGLIFLOZIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: LAURUS LABS LTD · Approved 2025-09-29
Drug application
- FDA Application #
ANDA210503- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- CANAGLIFLOZIN
- Generic name
- Canagliflozin
- Active ingredients
- CANAGLIFLOZIN
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- LAURUS LABS LTD
- First approval
- 2025-09-29
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown